These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis. Kurai D; Mizukami A; Preckler V; Verelst F; Molnar D; Matsuki T; Ho Y; Igarashi A Expert Rev Vaccines; 2024; 23(1):303-311. PubMed ID: 38426479 [TBL] [Abstract][Full Text] [Related]
3. Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies. Mazur NI; Caballero MT; Nunes MC Lancet; 2024 Sep; 404(10458):1143-1156. PubMed ID: 39265587 [TBL] [Abstract][Full Text] [Related]
4. Clinical and Epidemiologic Characteristics of Hospitalized Patients with Laboratory-Confirmed Respiratory Syncytial Virus Infection in Eastern China between 2009 and 2013: A Retrospective Study. Cui D; Feng L; Chen Y; Lai S; Zhang Z; Yu F; Zheng S; Li Z; Yu H PLoS One; 2016; 11(11):e0165437. PubMed ID: 27802292 [TBL] [Abstract][Full Text] [Related]
5. RSV associated hospitalizations in children in Karachi, Pakistan: Implications for vaccine prevention strategies. Ali A; Yousafzai MT; Waris R; Jafri F; Aziz F; Abbasi IN; Zaidi A J Med Virol; 2017 Jul; 89(7):1151-1157. PubMed ID: 28092107 [TBL] [Abstract][Full Text] [Related]
6. Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults. Papi A; Ison MG; Langley JM; Lee DG; Leroux-Roels I; Martinon-Torres F; Schwarz TF; van Zyl-Smit RN; Campora L; Dezutter N; de Schrevel N; Fissette L; David MP; Van der Wielen M; Kostanyan L; Hulstrøm V; N Engl J Med; 2023 Feb; 388(7):595-608. PubMed ID: 36791160 [TBL] [Abstract][Full Text] [Related]
7. Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the Philippines. Ueno F; Tamaki R; Saito M; Okamoto M; Saito-Obata M; Kamigaki T; Suzuki A; Segubre-Mercado E; Aloyon HD; Tallo V; Lupisan SP; Oshitani H; Influenza Other Respir Viruses; 2019 Jul; 13(4):339-353. PubMed ID: 30891896 [TBL] [Abstract][Full Text] [Related]
8. Capturing respiratory syncytial virus season in Belgium using the influenza severe acute respiratory infection surveillance network, season 2018/19. Subissi L; Bossuyt N; Reynders M; Gérard M; Dauby N; Bourgeois M; Delaere B; Quoilin S; Van Gucht S; Thomas I; Barbezange C Euro Surveill; 2020 Oct; 25(39):. PubMed ID: 33006303 [TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus infection in older adults: an under-recognized problem. Branche AR; Falsey AR Drugs Aging; 2015 Apr; 32(4):261-9. PubMed ID: 25851217 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology and clinical characteristics of respiratory syncytial virus infections among children and adults in Mexico. Gamiño-Arroyo AE; Moreno-Espinosa S; Llamosas-Gallardo B; Ortiz-Hernández AA; Guerrero ML; Galindo-Fraga A; Galán-Herrera JF; Prado-Galbarro FJ; Beigel JH; Ruiz-Palacios GM; Noyola DE; Influenza Other Respir Viruses; 2017 Jan; 11(1):48-56. PubMed ID: 27439650 [TBL] [Abstract][Full Text] [Related]
11. Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States. La EM; Bunniran S; Garbinsky D; Reynolds M; Schwab P; Poston S; Harrington L Hum Vaccin Immunother; 2024 Dec; 20(1):2303796. PubMed ID: 38297921 [TBL] [Abstract][Full Text] [Related]
12. Hospitalizations for acute lower respiratory tract infection due to respiratory syncytial virus in Thailand, 2008-2011. Naorat S; Chittaganpitch M; Thamthitiwat S; Henchaichon S; Sawatwong P; Srisaengchai P; Lu Y; Chuananon S; Amornintapichet T; Chantra S; Erdman DD; Maloney SA; Akarasewi P; Baggett HC J Infect Dis; 2013 Dec; 208 Suppl 3():S238-45. PubMed ID: 24265483 [TBL] [Abstract][Full Text] [Related]
13. Severe outcomes associated with respiratory viruses in newborns and infants: a prospective viral surveillance study in Jordan. Khuri-Bulos N; Lawrence L; Piya B; Wang L; Fonnesbeck C; Faouri S; Shehabi A; Vermund SH; Williams JV; Halasa NB BMJ Open; 2018 May; 8(5):e021898. PubMed ID: 29780032 [TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus infection in elderly and high-risk adults. Falsey AR; Hennessey PA; Formica MA; Cox C; Walsh EE N Engl J Med; 2005 Apr; 352(17):1749-59. PubMed ID: 15858184 [TBL] [Abstract][Full Text] [Related]
15. Safety and Immunogenicity of a Revaccination With a Respiratory Syncytial Virus Prefusion F Vaccine in Older Adults: A Phase 2b Study. Leroux-Roels I; Van Ranst M; Vandermeulen C; Abeele CV; De Schrevel N; Salaun B; Verheust C; David MP; Kotb S; Hulstrøm V J Infect Dis; 2024 Feb; 229(2):355-366. PubMed ID: 37699064 [TBL] [Abstract][Full Text] [Related]
16. Comparative study on the epidemiological characteristics and hazards of respiratory syncytial virus and influenza virus infections among elderly people. Yu J; Liu N; Zhu Y; Wang W; Fan X; Yuan X; Xu J; Zheng B; Luan L BMC Infect Dis; 2024 Oct; 24(1):1129. PubMed ID: 39385082 [TBL] [Abstract][Full Text] [Related]
17. Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. Nguyen-Van-Tam JS; O'Leary M; Martin ET; Heijnen E; Callendret B; Fleischhackl R; Comeaux C; Tran TMP; Weber K Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36384703 [TBL] [Abstract][Full Text] [Related]
18. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Li Y; Wang X; Blau DM; Caballero MT; Feikin DR; Gill CJ; Madhi SA; Omer SB; Simões EAF; Campbell H; Pariente AB; Bardach D; Bassat Q; Casalegno JS; Chakhunashvili G; Crawford N; Danilenko D; Do LAH; Echavarria M; Gentile A; Gordon A; Heikkinen T; Huang QS; Jullien S; Krishnan A; Lopez EL; Markić J; Mira-Iglesias A; Moore HC; Moyes J; Mwananyanda L; Nokes DJ; Noordeen F; Obodai E; Palani N; Romero C; Salimi V; Satav A; Seo E; Shchomak Z; Singleton R; Stolyarov K; Stoszek SK; von Gottberg A; Wurzel D; Yoshida LM; Yung CF; Zar HJ; ; Nair H; Lancet; 2022 May; 399(10340):2047-2064. PubMed ID: 35598608 [TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis. Payne AB; Watts JA; Mitchell PK; Dascomb K; Irving SA; Klein NP; Grannis SJ; Ong TC; Ball SW; DeSilva MB; Natarajan K; Sheffield T; Bride D; Arndorfer J; Naleway AL; Koppolu P; Fireman B; Zerbo O; Timbol J; Goddard K; Dixon BE; Fadel WF; Rogerson C; Allen KS; Rao S; Mayer D; Barron M; Reese SE; Rowley EAK; Najdowski M; Ciesla AA; Mak J; Reeves EL; Akinsete OO; McEvoy CE; Essien IJ; Tenforde MW; Fleming-Dutra KE; Link-Gelles R Lancet; 2024 Oct; 404(10462):1547-1559. PubMed ID: 39426837 [TBL] [Abstract][Full Text] [Related]
20. Prevalence, risk factors and clinical characteristics of respiratory syncytial virus-associated lower respiratory tract infections in Kelantan, Malaysia. Teck KS; Mac Guad R; Van Rostenberghe AH; Hua GS J Med Virol; 2019 Sep; 91(9):1608-1615. PubMed ID: 31074499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]